These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2133324)

  • 1. Lymphokines and cancer.
    Cavallo G
    G Batteriol Virol Immunol; 1990; 83(1-12):156-63. PubMed ID: 2133324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of murine lymphokine production in vivo. Ultraviolet radiation exposure depresses IL-2 and enhances IL-4 production by T cells through an IL-1-dependent mechanism.
    Araneo BA; Dowell T; Moon HB; Daynes RA
    J Immunol; 1989 Sep; 143(6):1737-44. PubMed ID: 2506268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intercellular communication: role of soluble factors in cellular immune responses.
    Klesius PH
    J Am Vet Med Assoc; 1982 Nov; 181(10):1015-21. PubMed ID: 6816771
    [No Abstract]   [Full Text] [Related]  

  • 6. IL-2 gene transduction in malignant cells: applications in cancer containment.
    Roth C; Mir L; Cressent M; Quintin-Colonna F; Ley V; Fradelizi D; Kourilsky P
    Bone Marrow Transplant; 1992; 9 Suppl 1():174-5. PubMed ID: 1504663
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
    J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of lymphokines in the generation of cytotoxic T lymphocytes].
    Kasakura S
    Rinsho Ketsueki; 1984 Apr; 25(4):479-87. PubMed ID: 6236311
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on lymphokine activated killer cells in the rat: analysis of precursor and effector cell phenotype and relationship to natural killer cells.
    Hiserodt JC; Vujanovic NL; Reynolds CW; Herberman RB; Cramer DV
    Prog Clin Biol Res; 1987; 244():137-46. PubMed ID: 2958869
    [No Abstract]   [Full Text] [Related]  

  • 10. Combinational IL-2/IL-15 induction does not further enhance IL-15-induced lymphokine-activated killer cell cytotoxicity against human leukemia/lymphoma cells.
    Ozdemir O; Savaşan S
    Clin Immunol; 2005 Jun; 115(3):240-9. PubMed ID: 15893691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.
    Noelle RJ; McCann J; Marshall L; Bartlett WC
    J Immunol; 1989 Sep; 143(6):1807-14. PubMed ID: 2476483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells.
    Kornbluth RS; Gregory SA; Edgington TS
    J Immunol; 1988 Sep; 141(6):2006-15. PubMed ID: 3139748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine-mediated induction of antigen-presenting ability in thymic stromal cells.
    Ransom J; Fischer M; Mercer L; Zlotnik A
    J Immunol; 1987 Oct; 139(8):2620-8. PubMed ID: 3116089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.
    Keller R; Keist R; Van der Meide PH; Groscurth P; Aguet M; Leist TP
    J Immunol; 1987 Apr; 138(7):2366-71. PubMed ID: 3104463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer immunotherapy: immunologic bases, reality and hopes].
    Dietrich PY; Farace F; Caignard A; Escudier B; Triebel F
    Bull Cancer; 1993 Jul; 80(7):584-600. PubMed ID: 8204939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine neoplasms induce tumor-specific immune responses that prolong the lives of tumor-bearing mice.
    Sun T; Kim TS; Waltz MR; Cohen EP
    Cancer Gene Ther; 1995 Sep; 2(3):183-90. PubMed ID: 8528961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity.
    Forni G; Giovarelli M; Santoni A; Modesti A; Forni M
    J Immunol; 1987 Jun; 138(11):4033-41. PubMed ID: 2953796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.